Brain-Type Creatine Kinase Release from Cultured Osteoclasts Exposed to Neridronate in Children Affected by Osteogenesis Imperfecta Type 1

Brain-Type Creatine Kinase Release from Cultured Osteoclasts Exposed to Neridronate in Children Affected by Osteogenesis Imperfecta Type 1

Brain-type creatine kinase (CK-BB) increases during osteoclastogenesis, with high circulating amounts in type I osteogenesis imperfecta (OI) following treatment with neridronate, a bisphosphonate able to inhibit osteoclast activity and survival. The aim of this study was to demonstrate the correlati...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Maria Felicia Faienza, Albina Tummolo, Mauro Celli, Roberto Finocchiaro, Laura Piacente, Francesca Di Serio, Grazia Paola Nicchia, Giacomina Brunetti, Patrizia D’Eufemia
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: MDPI AG 2023-02-01
Cyfres:Biomedicines
Pynciau:
osteogenesis imperfecta
CK-BB
osteoclastogenesis
neridronate
Mynediad Ar-lein:https://www.mdpi.com/2227-9059/11/2/458

Rhyngrwyd

https://www.mdpi.com/2227-9059/11/2/458

Eitemau Tebyg